Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. (Q50848684)
Jump to navigation
Jump to search
scientific article published on 14 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. |
scientific article published on 14 October 2014 |
Statements
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Rosemary Balleine
1 reference
Laura Galletta
1 reference
Dariush Etemadmoghadam
1 reference
Sally M Hunter
1 reference
Raghwa Sharma
1 reference
Yoke-Eng Chiew
1 reference
Sian Fereday
1 reference
Jillian Hung
1 reference
Russell Hogg
1 reference
Gerard V Wain
1 reference
Catherine Emmanuel
1 reference
Joshy George
1 reference
Peter Russell
1 reference
Catherine Kennedy
1 reference
Alison Brand
1 reference
Laura MacConaill
1 reference
Emanuele Palescandolo
1 reference
Hongdo Do
1 reference
Australian Ovarian Cancer Study (AOCS)
1 reference
14 October 2014
1 reference
20
1 reference
24
1 reference
6618-6630
1 reference